Alcohol Use Disorder (AUD): Clinical Trials

30 trials for Alcohol Use Disorder (AUD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 recruiting, 6 completed, 6 not yet recruiting, 4 active not recruiting. 30 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 230Recruiting 10, Completed 6, Not yet recruiting 6, Active not recruiting 4, Unknown 2, Enrolling by invitation 1, Terminated 1
Phase 12Not yet recruiting 1, Recruiting 1
Phase 32Enrolling by invitation 1, Recruiting 1

Follow Alcohol Use Disorder (AUD): new trials by email Literature Review of Alcohol Use Disorder (AUD) trials Research Report on Alcohol Use Disorder (AUD)

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biphasic Effect of Alcohol on Pain
Alcohol (IV), Saline (0.9%, sterile, for infusion) - Alcohol Use, Chronic Low-back Pain (cLBP)
Phase 2Not yet recruitingYale University1322027-02-012026-11-17
Pregnenolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study
Brexanolone - Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD)
Phase 2Not yet recruitingPharmacotherapies for Alcohol and Substance Use Disorders Alliance402027-01-152026-09-21
OEA for Young Adults With Alcohol Use Disorder
oleoylethanolamide - Alcohol Use Disorder (AUD)
Phase 2Not yet recruitingMedical University of South Carolina422027-01-152026-11-17
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
Cannabidiol (CBD), Placebo - Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification
Phase 2 / Phase 3RecruitingJohns Hopkins University1052026-10-212026-11-03
Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive Disorder
Pregnenolone, Placebo - Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD)
Phase 2Not yet recruitingSherwood Brown, MD, PhD1002026-10-012026-08-24
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Psilocybin 25 mg, Placebo - Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD)
Phase 2RecruitingCentre for Addiction and Mental Health302026-03-232026-10-26
Probenecid Administration for Alcohol Craving and Consumption
Probenecid Oral Tablet, Placebo Oral Tablet - Alcohol Use Disorder (AUD), Alcohol Consumption
Phase 2RecruitingBrown University1202026-03-142026-03-17
LSD Treatment for Persons With Alcohol Use Disorder
LSD, Active placebo - Alcohol Use Disorder (AUD)
Phase 2RecruitingFelix Mueller1282026-01-272026-10-07
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
semaglutide - Alcohol Use Disorder (AUD), HIV
Phase 2RecruitingYale University302026-01-152026-03-24
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
Tirzepatide, Take Control CBT Module, Placebo - Alcohol Use Disorder (AUD), Overweight or Obese
Phase 2Not yet recruitingSouth West Sydney Local Health District462026-01-152025-12-18
Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
Ketamine, Cognitive Behavioural Therapy - Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD)
Phase 1 / Phase 2Not yet recruitingSouth West Sydney Local Health District202025-12-102025-11-25
Study of Tirzepatide for Recovery and Alcohol Use Management
Tirzepatide, Saline Placebo - Alcohol Use Disorder (AUD)
Phase 2RecruitingBrigham and Women's Hospital202025-09-152026-07-09
Suvorexant for Treatment of AUD and PTSD
Suvorexant, Placebo - Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD)
Phase 2RecruitingPharmacotherapies for Alcohol and Substance Use Disorders Alliance762025-07-162026-10-14
PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
Psilocybin 25 mg, Maltodextrin (Placebo) - Alcohol Use Disorder (AUD), PTSD
Phase 2Active not recruitingNathan Brashares Sackett402025-06-012026-08-13
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
Ketamine, Real-time fMRI Neurofeedback Training, Placebo - Alcohol Abuse/Dependence, Alcohol Use Disorder (AUD)
Phase 2RecruitingDr. med. Marcus Herdener752025-06-012025-12-05
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
Pemvidutide, Placebo - Alcohol Use Disorder (AUD)
Phase 2CompletedAltimmune, Inc.1002025-05-152026-07-31
Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms
Siemens 3T PRISMA MR Scanner, PET/CT Scanner, Suvorexant - Healthy Volunteers, Alcohol Use Disorder (AUD)
Phase 1 / Phase 2RecruitingNational Institute on Alcohol Abuse and Alcoholism (NIAAA)1802024-11-212026-10-19
A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder
TMP-301, Placebo - Alcohol Use Disorder (AUD)
Phase 2TerminatedTempero Bio, Inc.1102024-11-142026-04-13
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Psilocybin - Alcohol Use Disorder (AUD)
Phase 2UnknownAnders Fink-Jensen, MD, DMSci102023-02-092024-07-12
Ibudilast for Treating Alcohol Use Disorder
Ibudilast, Medical management, Placebo - Alcohol Use Disorder (AUD), Alcoholism
Phase 2Active not recruitingUniversity of Pennsylvania502023-01-142026-06-03

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Alcoholism (30)  ·  Alcohol Drinking (5)  ·  Substance-Related Disorders (5)  ·  Stress Disorders, Post-Traumatic (4)  ·  Depressive Disorder, Major (3)  ·  Obesity (2)  ·  Overweight (2)  ·  Alcohol Abstinence (1)  ·  Alcohol-Related Disorders (1)  ·  Anxiety Disorders (1)  ·  Behavior, Addictive (1)  ·  Depression (1)  ·  Mental Disorders (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Tobacco Use Disorder (1)

Broader conditions

Chemically-Induced Disorders (30)  ·  Alcohol-Related Disorders (29)  ·  Mental Disorders (29)  ·  Substance-Related Disorders (25)  ·  Behavior (8)  ·  Drinking Behavior (6)  ·  Stress Disorders, Traumatic (4)  ·  Trauma and Stressor Related Disorders (4)  ·  Depressive Disorder (3)  ·  Mood Disorders (3)  ·  Body Weight (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Overnutrition (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Psilocybin (3)  ·  suvorexant (3)  ·  Cannabidiol (2)  ·  Cognitive Behavioral Therapy (2)  ·  Ketamine (2)  ·  Practice Management, Medical (2)  ·  Tirzepatide (2)  ·  ASP8062 (1)  ·  Acetylcysteine (1)  ·  Doxazosin (1)  ·  Ethanol (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Lysergic Acid Diethylamide (1)  ·  Orexin Receptor Antagonists (1)  ·  Pregnenolone (1)

Sponsors

South West Sydney Local Health District (3)  ·  University of Pennsylvania (3)  ·  Brown University (2)  ·  Medical University of South Carolina (2)  ·  National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2)  ·  Pharmacotherapies for Alcohol and Substance Use Disorders Alliance (2)  ·  Washington State University (2)  ·  Yale University (2)  ·  Altimmune, Inc. (1)  ·  Anders Fink-Jensen, MD, DMSci (1)  ·  Brigham and Women's Hospital (1)  ·  Centre for Addiction and Mental Health (1)  ·  Dr. med. Marcus Herdener (1)  ·  Felix Mueller (1)  ·  Johns Hopkins University (1)

Countries

United States (22)  ·  Australia (3)  ·  Switzerland (2)  ·  Canada (1)  ·  Denmark (1)

Top investigators

Anders Fink-Jensen, Professor (1)  ·  Barbara J. Mason, Ph.D. (1)  ·  Carolina Haass-Koffler, PharmD, PhD (1)  ·  Carolina L Haass-Koffler, PHARMD, PHD (1)  ·  Corinde E Wiers, Ph.D. (1)  ·  David Woliinsky, MD (1)  ·  E. Jennifer Edelman, MD, MHS (1)  ·  Henry R Kranzler, M.D. (1)  ·  Henry R Kranzler, MD (1)  ·  Ismene L. Petrakis, M.D. (1)  ·  Joao P. De Aquino, M.D. (1)  ·  Joji Suzuki, MD (1)  ·  Judith Prochaska, PhD (1)  ·  Lara Ray, PhD (1)  ·  MacKenzie R. Peltier, Ph.D. (1)

Results publications

PMID 26037245, PMID 28551590, PMID 34049101, PMID 35229945, PMID 36813084, PMID 39252861, PMID 40018886, PMID 40445294, PMID 40548528, PMID 41630040, PMID 42035882

NIH funding

P01AA029545 (1), P60AA006420 (1), R01AA023192 (1), R01AA032917 (1), R01AA033156 (1)